表纸
市场调查报告书

全球实验室自动化系统市场

Global Laboratory Automation Systems Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 301119
出版日期 内容资讯 英文 119 Pages
订单完成后即时交付
价格
Back to Top
全球实验室自动化系统市场 Global Laboratory Automation Systems Market 2019-2023
出版日期: 2019年01月24日内容资讯: 英文 119 Pages
简介

所谓实验室自动化,是指研究、品质保证、诊断实验室中,包含最尖端的工作流程的各种例行性工作的技术和设备的利用,透过自动化,可实现迅速的高处理能力,同时分析庞大数量的样品。实验室自动化系统,主要利用于临床试验和药物研发的领域,有单独或是综合性的实验室系统形态。全球实验室自动化系统的市场,预计从2013年到2018年,以年平均5.32%的成长率发展。

本报告提供全球实验室自动化系统市场成长预测调查分析、各种系统的收益预测、主要供应商概要及配合措施与竞争环境、市场的各种影响因素分析、地区趋势等汇整资料,为您概述为以下内容。

为您概述为以下内容。

第1章 摘要整理

第2章 简称清单

第3章 调查范围

  • 市场概要
  • 主要的产品

第4章 市场调查手法

  • 市场调查流程
  • 调查手法

第5章 简介

第6章 市场环境

  • 市场概要
  • 市场规模与预测
  • 波特的五力分析

第7章 各用途市场区分

  • 全球临床实验室自动化系统市场
  • 全球药物研发实验室自动化系统市场

第8章 地区区分

第9章 购买标准

第10章 市场促进因素

第11章 成长推进因素与其影响

第12章 市场上课题

第13章 成长推进因素及课题的影响

第14章 市场趋势

第15章 市场趋势与其影响

第16章 供应商环境

  • 竞争模式
    • 主要消息
    • M&A
  • 市场占有率分析
  • 其他受关注供应商

第17章 主要供应商分析

  • Danaher Corp.
  • PerkinElmer Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
    • 主要资料
    • 产业概要
    • 产业区分
    • 各产业分类收益
    • 收益的转变
    • 各地区销售额
    • 产业策略
    • SWOT分析等

第18章 本系列的其他报告

图表

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR30736

About this market

Vendors have started offering software as an additional service with their laboratory automation systems, to maintain customer loyalty and ensure quality results. These software services are equipped with an intuitive and flexible user interface, which enables the analysis of data sample. These software services resemble the manual plating procedure. Apart from being compliant with regulatory recommendations such as the Certificates of Analysis (COA) and the Certificates of Conformance (COC). These software services can be altered according to the needs of end-users. It is versatile and can run on different platforms such as Windows XP, Windows Vista: and Windows 7. Such software services have been designed specifically for life sciences research and enhance the drug discovery process. Additionally, these programs support real-time analysis and save and send the data in several common file formats. They have built-in calculations for data analysis and help save time and generate high-quality results, thereby driving the market. Technavio's analysts have predicted that the laboratory automation systems market will register a CAGR of over 7% by 2023.

Market Overview

Rising use of automated solutions in healthcare

Fully automated laboratory solutions can help save cost and generate accurate results. Automated solutions can also help save the time of healthcare professionals, as automation replaces manually intensive tasks: which allows researchers to devote more time to analysis and data interpretation. Automation solutions in healthcare, which include automated systems, software, and other services, also improve laboratory productivity, as they reduce the chances of human errors.

Lack of adoption of automated solutions by small-scale and medium-scale laboratories

Medium and small-scale laboratories handle a lower volume of samples as they are mostly established to address specific applications such as diagnosis and testing of biological samples. These laboratories lack adequate budgets. staff, or planning. Therefore, they do not prioritize automation. Moreover, small-and medium-scale laboratories are reluctant to procure laboratory automation systems due to lack of floor space.

For the detailed list of factors that will drive and challenge the growth of the laboratory automation systems market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be mildly fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
  • Clinical and reference laboratories - Market size and forecast 2018-2023
  • Academic institutes and research organizations - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Clinical and reference laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Clinical and reference laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Agilent Technologies - Vendor overview
  • Exhibit 46: Agilent Technologies - Business segments
  • Exhibit 47: Agilent Technologies - Organizational developments
  • Exhibit 48: Agilent Technologies - Geographic focus
  • Exhibit 49: Agilent Technologies - Segment focus
  • Exhibit 50: Agilent Technologies - Key offerings
  • Exhibit 51: Danaher - Vendor overview
  • Exhibit 52: Danaher - Business segments
  • Exhibit 53: Danaher - Organizational developments
  • Exhibit 54: Danaher - Geographic focus
  • Exhibit 55: Danaher - Segment focus
  • Exhibit 56: Danaher - Key offerings
  • Exhibit 57: PerkinElmer - Vendor overview
  • Exhibit 58: PerkinElmer - Business segments
  • Exhibit 59: PerkinElmer - Organizational developments
  • Exhibit 60: PerkinElmer - Geographic focus
  • Exhibit 61: PerkinElmer - Segment focus
  • Exhibit 62: PerkinElmer - Key offerings
  • Exhibit 63: QIAGEN - Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
Back to Top